We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Cardiac CT Offers a Cost-Effective Approach to Diagnose Low-Risk Chest Pain Patients

By HospiMedica International staff writers
Posted on 26 May 2009
Using cardiac computed tomography (CT) to diagnose low-risk patients with chest pain is significantly less expensive--44% less than the standard of care (SOC)--and can decrease the length of hospital stay up to 20 hours.

Fifty-three low-risk chest pain patients were compared by using results from a cardiac CT-based workup and a traditional standard of care workup using nuclear stress testing. More...
"Nothing was cut from the standard of care workup,” said Janet May, M.S., from the University of Washington (Seattle, WA, USA), and lead author of the study.

"The current emergency department standard-of-care workup for low risk chest pain patients often involves serial cardiac enzymes, serial ECGs, and a nuclear cardiac stress test. Such a workup can take up to 30 hours and is expensive. The mean cost for the SOC workup in this study was US$7,597,” said Ms. May. "With new lower dose cardiac CT options available that lower the patient radiation dose, patients get a faster evaluation and are discharged much sooner with a cardiac CT; in less than six hours,” she said. "Once you know the case is a low risk patient with chest pain, the sooner the cardiac CT is done, the better. "Speed results in cost savings without compromising accuracy.”

According to Ms. May, emergency rooms across the United States are besieged with congestion and escalating cost issues. She noted that over six million patients present to US emergency rooms each year with chest pain and most of these are low risk. "Dealing with these patients faster and with greater cost effectiveness is a big step toward ameliorating congestion and spiraling cost,” she said.

This study was presented at the 2009 American Roentgen Ray Society (ARRS) annual meeting in Boston, MA, USA, on April 27, 2009.

Related Links:

University of Washington




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.